XML 11 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Document And Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2023
Mar. 21, 2024
Jun. 30, 2023
Document Information [Line Items]      
Entity, Registrant Name NOVABAY PHARMACEUTICALS, INC.    
Document, Type 10-K/A    
Document, Annual Report true    
Document, Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document, Fiscal Period Focus FY    
Document, Fiscal Year Focus 2023    
Document, Transition Report false    
Entity, File Number 001-33678    
Entity, Incorporation, State or Country Code DE    
Entity, Tax Identification Number 68-0454536    
Entity, Address, Address Line One 2000 Powell Street, Suite 1150    
Entity, Address, City or Town Emeryville    
Entity, Address, State or Province CA    
Entity, Address, Postal Zip Code 94608    
City Area Code 510    
Local Phone Number 899-8800    
Title of 12(b) Security Common Stock    
Trading Symbol NBY    
Security Exchange Name NYSE    
Entity, Well-known Seasoned Issuer No    
Entity, Voluntary Filers No    
Entity, Current Reporting Status Yes    
Entity, Interactive Data, Current Yes    
Entity, Emerging Growth Company false    
Entity, Filer Category Non-accelerated Filer    
Entity, Small Business true    
ICFR Auditor Attestation Flag false    
Document, Financial Statement Error Correction Flag false    
Entity, Shell Company false    
Entity, Public Float     $ 3,050,485
Entity, Common Stock Shares, Outstanding   30,098,150  
Auditor Firm ID 100    
Auditor Name WithumSmith+Brown, PC    
Auditor Location San Francisco, California    
Amendment Description This Amendment No. 1 on Form 10-K/A (this “Amendment”) amends the Annual Report on Form 10-K of NovaBay Pharmaceuticals, Inc. for the fiscal year ended December 31, 2023, as filed with the Securities and Exchange Commission on March 26, 2024 (the “Original Filing”). Exhibit 4.1 (Description of Securities) (the “Description of Securities”) was inadvertently omitted in the Original Filing.   This Amendment is being filed solely to file the Description of Securities. No other changes were made to the Original Filing. Further, no attempt has been made in this Amendment to modify or update the other disclosures presented in the Original Filing. This Amendment does not reflect events occurring after the filing of the Form 10-K (i.e., occurring after March 26, 2024) or modify or update those disclosures that may be affected by subsequent events. Accordingly, this Amendment should be read in conjunction with the Original Filing and the registrant’s other filings with the Securities and Exchange Commission.   In accordance with Rule 12b-15 of the Securities Exchange Act of 1934, as amended, this Amendment includes new certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002, as amended, dated as of the filing date of this Amendment.    
Amendment Flag true    
Entity, Central Index Key 0001389545